Lung Cavities in Chronic Thromboembolic Pulmonary Hypertension
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.75, article ID e1373, 4p, 2020
Resumo
OBJECTIVES: Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary hypertension (PH) that arises from obstruction of the pulmonary vessels by recanalized thromboembolic material. CTEPH has a wide range of radiologic presentations. Commonly, it presents as main pulmonary artery enlargement, peripheral vascular obstructions, bronchial artery dilations, and mosaic attenuation patterns. Nevertheless, other uncommon presentations have been described, such as lung cavities. These lesions may be solely related to chronic lung parenchyma ischemia but may also be a consequence of concomitant chronic infectious conditions. The objective of this study was to evaluate the different etiologies that cause lung cavities in CTEPH patients. METHODS: A retrospective data analysis of the medical records of CTEPH patients in a single reference PH center that contained or mentioned lung cavities was conducted between 2013 and 2016. RESULTS: Seven CTEPH patients with lung cavities were identified. The cavities had different sizes, locations, and wall thicknesses. In two patients, the cavities were attributed to pulmonary infarction; in 5 patients, an infectious etiology was identified. CONCLUSION: Despite the possibility of being solely associated with chronic lung parenchyma ischemia, most cases of lung cavities in CTEPH patients were associated with chronic granulomatous diseases, reinforcing the need for active investigation of infectious agents in this setting.
Palavras-chave
Chronic Thromboembolic Pulmonary Hypertension, Lung Cavities, Pulmonary Infarction, Chronic Granulomatous Diseases, Infection
Referências
- AUGER WR, 1992, RADIOLOGY, V182, P393, DOI 10.1148/radiology.182.2.1732955
- Fernandes CJCD, 2016, J BRAS PNEUMOL, V42, P146, DOI [10.1590/S1806-37562016042020068, 10.1590/S1806-37562016000000068]
- Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704
- Fernandes CJ, 2019, RESPIRATION, V98, P253, DOI 10.1159/000501342
- Fernandes CJ, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0119-2018
- Fernandes CJCDS, 2018, J BRAS PNEUMOL
- Gadkowski LB, 2008, CLIN MICROBIOL REV, V21, P305, DOI 10.1128/CMR.00060-07
- Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
- Gavilanes-Oleas FA, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e216
- Grosse C, 2010, RADIOGRAPHICS, V30, P1753, DOI 10.1148/rg.307105710
- Harris H, 2008, J RADIOL CASE REP, V2, P11, DOI 10.3941/jrcr.v2i3.50
- Jamieson S, 2018, SEMIN INTERVENT RAD, V35, P136, DOI 10.1055/s-0038-1651481
- King MA, 1998, AM J ROENTGENOL, V170, P955, DOI 10.2214/ajr.170.4.9530043
- Mahmud E, 2018, J AM COLL CARDIOL, V71, P2468, DOI 10.1016/j.jacc.2018.04.009
- Morel S, 2012, REV MAL RESPIR, V29, P723, DOI 10.1016/j.rmr.2011.12.018
- Okuda K, 2014, INTERNAL MED, V53, P1829, DOI 10.2169/internalmedicine.53.2252
- Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438
- Wilinska Ewelina, 2014, Pneumonol Alergol Pol, V82, P495, DOI 10.5603/PiAP.2014.0066